All
Search
Images
Videos
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Dr. Shaw Compares Crizotinib and Chemotherapy in NSCLC
Jul 19, 2013
onclive.com
Ceritinib in Crizotinib-Resistant NSCLC | OncLive
Jan 13, 2016
onclive.com
Crizotinib for ALK-Rearranged NSCLC | OncLive
1 week ago
onclive.com
Dr. Crinò on Crizotinib in ALK-Positive NSCLC
Oct 1, 2013
onclive.com
ELCC 2025 Insights: Taletrectinib vs. Crizotinib in ROS1 NSCLC
26 views
5 months ago
vumedi.com
ALTA II: Brigatinib in Crizotinib-Resistant ALK+ NSCLC | OncLive
5 days ago
onclive.com
Dr. Kris Discusses Crizotinib in ALK-Positive Lung Cancer
Nov 2, 2012
onclive.com
Patterns of Progression on Crizotinib for ALK NSCLC | OncLive
Apr 27, 2017
onclive.com
Dr. West on ALK-NSCLC Crizotinib Survival Benefit | OncLive
Jun 30, 2011
onclive.com
Dr. Li Discusses the PROFILE Crizotinib Clinical Trials | OncLive
2 weeks ago
onclive.com
Lorlatinib vs Crizotinib in Treatment-Naive Patients With Advanced AL
…
Jun 17, 2024
onclive.com
Dr. Shaw on Monitoring Crizotinib-Related Side Effects | OncLive
2 weeks ago
onclive.com
ALTA-1L: Brigatinib Versus Crizotinib for ALK NSCLC | OncLive
Jul 12, 2019
onclive.com
Dr. Rotow on First-Line Brigatinib Versus Crizotinib in ALK+ NSCLC
…
2 weeks ago
onclive.com
Ensartinib Shows Superior Efficacy to Crizotinib in Advanced ALK-Po
…
Oct 10, 2021
ascopost.com
Dr. Camidge on Crizotinib as a ROS1 Inhibitor in NSCLC | OncLive
1 week ago
onclive.com
Dr. Ou on the Use of Crizotinib in Patients With ROS1-Rearranged N
…
May 5, 2018
onclive.com
Nuvation Bio Inc.: Nuvation Bio to Present Matching-adjusted Indirec
…
1 week ago
finanznachrichten.de
1:30
Evaluating the FDA Approval of taletrectinib for ROS+ NSCLC
30 views
3 weeks ago
YouTube
VJOncology
7:58
The Phase 3 E4512 Trial in ALK+ NSCLC: Insights From the IASLC
…
3 weeks ago
YouTube
Lung Cancers Today
23:59
WCLC 2025 Highlights: FLAURA2, HARMONi, ALCHEMIST with Dr. B
…
739 views
2 weeks ago
YouTube
OncBrothers: Practice-Changing Cancer Discus…
2:14
New ALK Inhibitor Drugs vs Xalkori (Crizotinib) for ALK+ Lung Cancer
…
1.7K views
May 30, 2014
YouTube
GRACE - Global Resource for Advancing Canc…
Dr. Kris on the Crizotinib Clinical Trials
Mar 23, 2011
onclive.com
3:59
ALTA-1L: final overall survival results of brigatinib vs crizotinib f
…
639 views
Oct 5, 2021
YouTube
VJOncology
2:19
Imatinib: The Breakthrough in Leukemia Treatment
5.3K views
Nov 22, 2018
YouTube
Onco
Dr. Chae on Using Crizotinib to Treat MET+ NSCLC
232 views
Feb 28, 2020
YouTube
OncLive
IDEAYA Reports Encouraging Clinical Activity From Darovaserti
…
Dec 7, 2021
nasdaq.com
ALEX: alectinib is the best first-line therapy available for ALK-positive
…
2.4K views
Aug 22, 2018
YouTube
VJOncology
ALTA-1L: brigatinib vs crizotinib in ALK+ aNSCLC
166 views
Jan 31, 2020
YouTube
VJOncology
0:57
FDA Approves Mirikizumab, a Promising Induction and Maintena
…
420 views
Oct 29, 2023
YouTube
Global Health Today
See more videos
More like this
Feedback
Feedback